AVANIR Pharmaceuticals (AVNR) Announces Accelerated Development Path for AVP-786 Following Successful Pre-IND Meeting With FDA
6/5/2013 10:23:33 AM
More...
|
AVANIR Pharmaceuticals (AVNR) to Participate in Two Upcoming Investor Conferences
5/22/2013 7:28:58 AM
More...
|
AVANIR Pharmaceuticals (AVNR) Reports Fiscal 2013 Second Quarter Financial and Business Results
5/9/2013 6:26:08 AM
More...
|
AVANIR Pharmaceuticals (AVNR) Announces Date of Fiscal 2013 Second Quarter Financial Results and Conference Call
5/1/2013 7:00:58 AM
More...
|
AVANIR Pharmaceuticals (AVNR) Receives Positive CHMP Opinion for Approval of NUEDEXTA in Europe
4/29/2013 9:06:50 AM
More...
|
AVANIR Pharmaceuticals (AVNR) Announces Appointment of Corinne Nevinny to Board of Directors
3/12/2013 6:32:20 AM
More...
|
AVANIR Pharmaceuticals (AVNR) Announces Research Collaboration With Department of Veterans Affairs for Screening Pseudobulbar Affect (Pba) Symptoms in Veterans With Traumatic Brain Injury
3/6/2013 9:46:41 AM
More...
|
AVANIR Pharmaceuticals (AVNR) to Participate in Two Conferences in March
3/1/2013 7:53:26 AM
More...
|
AVANIR Pharmaceuticals (AVNR) to Present at RBC Capital Markets' 2013 Global Healthcare Conference
2/15/2013 6:45:30 AM
More...
|
AVANIR Pharmaceuticals (AVNR) Reports Fiscal 2013 First Quarter Financial and Business Results
2/8/2013 7:12:40 AM
More...
|
|